Metarrestin (ML246) is an orally active, specific perinucleolar compartment inhibitor that disrupts the nucleolar structure and inhibits RNA polymerase (Pol) I transcription. Metarrestin blocks metastatic development and extends survival in mouse cancer models.
Related Prodcuts:
Gemcitabine HCL; Bleomycin Sulfate; Temozolomide; Carmustine; CX-5461; Nelarabine; Cladribine; Trifluridine; Daptomycin; Fludarabine Phosphate